Manhattan Bridge Capital (NASDAQ:LOAN) Share Price Passes Below 200

Manhattan Bridge Capital (NASDAQ:LOAN) shares fell below their 200-day moving average during Wednesday trading, dipping to $4.18 and last trading at $4.23 versus a 200-day average of $4.52. Weiss Ratings downgraded LOAN from “hold (c)” to “hold (c-)” on May 11. The company reported Q1 EPS of $0.11 (vs. $0.12) and revenue of $2.07M (vs. $2.18M), and declared a $0.11 quarterly dividend payable July 15.

Original reporting
Published May 28, 2026, 9:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 28, 2026, 9:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Manhattan Bridge Capital (NASDAQ:LOAN) Share Price Passes Below 200 — source image
Decision brief

The 30-second read

$LOANBearishMed
01

Why it matters

Traders may treat the 200-day moving average breach as a momentum/positioning signal while the downgrade adds incremental bearish sentiment; dividend timing could partially offset downside for yield-seekers.

02

Market read

Company-specific technical weakness plus a recent rating downgrade creates a near-term trading catalyst for LOAN, even without fresh earnings/guidance.

03

What to watch

The article highlights a high dividend yield and upcoming payment date; some income-focused buyers may support the stock despite technical weakness.

Relevance 8/10Novelty 6/10Timing: during Wednesday trading (below 200-day moving average)

Background

Manhattan Bridge Capital (LOAN) is a small-cap BDC providing bridge loans, secured debt, and mezzanine financing to SMBs; the article focuses on a technical break and an analyst downgrade.

Company-level read

Ticker impact

$LOANBearishMedium confidence
Context

LOAN traded below its 200-day moving average and received a May 11 downgrade from Weiss Ratings, reinforcing near-term downside risk.

Expected impact

Bias toward further underperformance/volatility until price reclaims the 200-day area or new fundamentals emerge.

Evidence & confidence

The article provides a concrete technical trigger (below 200-day MA) and a specific analyst action (hold to hold c-). No new earnings or guidance is introduced beyond previously reported results and a scheduled dividend date.

Market effects

BDC/credit-services names may see mild read-across if technical weakness and rating downgrades persist in small-cap credit lenders.

No specific regional catalyst beyond US small-cap trading.

Limited global relevance; story is company-specific and technical/analyst-driven.

Counterpoint

The downgrade is only from “hold (c)” to “hold (c-)” and LOAN still shows positive profitability metrics (net margin, ROE), so selling pressure may be overdone.

Key entities

  • Manhattan Bridge Capital, Inc

    Subject of the article; LOAN shares moved below the 200-day moving average and were downgraded by Weiss Ratings.

  • Weiss Ratings

    Downgraded LOAN from hold (c) to hold (c-) on May 11.

Related articles

$LHXHigh

US air travel problems to persist into Sunday, with thousands of flights affected

US air travel disruptions continued into Sunday, with over 11,600 flights canceled or delayed. The FAA blamed the issue on a router problem at a contractor, L3Harris. The FAA expects operations to normalize by late Sunday. Airlines like Delta, United, American, and JetBlue canceled significant numbers of flights. The FAA and airlines are working to resolve the issue and prevent future disruptions.

$WWBHighAI 8/10

Windward Bio IPO Jumps 68% Though Twice-Yearly Asthma Antibody Has No Flare-Up Data Yet

Windward Bio Group AG (WWB) closed its first day of Nasdaq trading at $28.50, 68% above its $17 IPO price, with a market value of ~$1.7B. The company's asthma antibody, WIN378, targets TSLP and is designed for twice-yearly dosing. Windward raised ~$225M from its IPO and a concurrent private placement with Sanofi. The company has no approved products yet and has not reported exacerbation data for WIN378.

$NVDAMed

Nvidia Without Huang: What a Pause in AI Deals Means for Metals

Copper prices fell to a four-month low, with traders citing Nvidia's CEO Jensen Huang's resignation as a factor. Copper has declined weekly since mid-October, attributed to positioning in AI-linked stocks. Nvidia's shares dropped 4.3% on Thursday and 2% more on Friday. Analysts note Nvidia's role in funding AI deals, suggesting a potential pause could impact copper demand. Goldman Sachs sees subdued copper positioning if AI spending slows.

$NVDAHighAI 9/10

Huang’s Exit Puts Nvidia’s China Chip Access in Doubt

Nvidia's CEO Jensen Huang resigned amid reports of personal relationships tied to U.S. national security concerns. The board named CFO Colette Kress as interim CEO. Shares fell 4.3% on the news. The company faces U.S. congressional scrutiny over China chip access and potential export violations. Huang is set to testify before Congress.

$NVDAHighAI 8/10

Nvidia CEO Jensen Huang Exits as Shares Fall Amid Reports of Affairs

Nvidia CEO Jensen Huang has left the company amid reports of personal relationships, with reports varying on whether it was a resignation or board removal. Shares fell 8% in after-hours trading on Wednesday and again on Thursday. CFO Colette Kress will serve as interim CEO. The board is reportedly considering Arm CEO Rene Haas as a successor.